Paroxetine (Page 13 of 19)
Generalized Anxiety Disorder:
Table 4 enumerates adverse events that occurred at a frequency of 2% or more among GAD patients on paroxetine tablets who participated in placebo-controlled trials of 8-weeks duration in which patients were dosed in a range of 10 mg/day to 50 mg/day.
Generalized Anxiety Disorder | |||
Body System | Preferred Term | Paroxetine Tablets | Placebo |
( n = 735 ) | ( n = 529 ) | ||
Body as a Whole | Asthenia | 14% | 6% |
Headache | 17% | 14% | |
Infection | 6% | 3% | |
Abdominal Pain | |||
Trauma | |||
Cardiovascular | Vasodilation | 3% | 1% |
Dermatologic | Sweating | 6% | 2% |
Gastrointestinal | Nausea | 20% | 5% |
Dry Mouth | 11% | 5% | |
Constipation | 10% | 2% | |
Diarrhea | 9% | 7% | |
Decreased Appetite | 5% | 1% | |
Vomiting | 3% | 2% | |
Dyspepsia | — | — | |
Nervous System | Insomnia | 11% | 8% |
Somnolence | 15% | 5% | |
Dizziness | 6% | 5% | |
Tremor | 5% | 1% | |
Nervousness | 4% | 3% | |
Libido Decreased | 9% | 2% | |
Abnormal Dreams | |||
Respiratory System | Respiratory Disorder | 7% | 5% |
Sinusitis | 4% | 3% | |
Yawn | 4% | — | |
Special Senses | Abnormal Vision | 2% | 1% |
Urogenital System | Abnormal | 25% | 2% |
Ejaculation † | |||
Female Genital | 4% | 1% | |
Disorder † | |||
Impotence † | 4% | 3% |
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.